SCHEMBL7980767

SCHEMBL7980767

Cc1cccc(C)c1Nc1nc2ccccc2n2cncc12

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
LCK P06239 20/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7969709 0.91 LCK (1.00) LCK
SCHEMBL7969485 0.90 LCK (1.00) LCK
SCHEMBL7983808 0.89 LCK (0.80) LCK
SCHEMBL7970113 0.89 LCK (0.87) LCK
SCHEMBL7969632 0.89 LCK (0.80) LCK
SCHEMBL7969626 0.87 LCK (0.82) LCK
SCHEMBL4037488 0.87 LCK (0.77) LCK
SCHEMBL7980299 0.86 LCK (0.75) LCK
SCHEMBL7982128 0.84 LCK (1.00) LCK
SCHEMBL7984724 0.84 LCK (1.00) LCK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US claimed
WO-1999009845-A1 IMIDAZOQUINOXALINE PROTEIN TYROSINE KINASE INHIBITORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO claimed
US-6235740-B1 AUTOIMMUNE DISEASES; ANTIPROLIFERATION AGENTS BRISTOL-MYERS SQUIBB CO. 2001-05-22 US disclosed